A Cancer-Pain Analgesia as Prolonging Strategy of Surviving Time after Failure of Adjuvant Chemotherapy in Patient with Progressive Bone-Metastatic Hepatocellular Carcinoma

The hepatocellular carcinoma (HCC) with intrahepatic and bone metastasis shows poor survival of averagely 3 months. The bone metastasis and HCC itself might cause cancer-associated pain. An intrathecal (IT) analgesia might contribute to improve QOL and prolong surviving time (ST). A 71-year-old male...

Descripción completa

Detalles Bibliográficos
Autores principales: Inada, Yuji, Hattori, Seiji, Fujita, Yasuhiko, Amagai, Teruyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247531/
https://www.ncbi.nlm.nih.gov/pubmed/35949233
http://dx.doi.org/10.1159/000525118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247531/
https://www.ncbi.nlm.nih.gov/pubmed/35949233
http://dx.doi.org/10.1159/000525118

Ejemplares similares